Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Combining corticosteroids and non-ablative fractional laser therapy may effectively treat extensive alopecia areata.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The VVG stain effectively differentiates scar tissue from normal skin and helps classify types of permanent alopecia.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A woman's hair loss led to discovering she had lupus.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

Lupus can cause hair loss and nail changes, with treatments available for both.

Careful planning and accurate diagnosis are crucial for successful hair restoration surgery.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

New hair loss treatments could be improved by using combined biological markers.

CD2 might be a new treatment target for patchy alopecia areata.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

A boy's hair loss improved after tumor removal and vitamin D treatment, but hair loss returned despite normal vitamin D and no tumor regrowth.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.